Clinical Trials Logo

Appetitive Behavior clinical trials

View clinical trials related to Appetitive Behavior.

Filter by:
  • Completed  
  • Page 1 ·  Next »

NCT ID: NCT06163937 Completed - Appetitive Behavior Clinical Trials

Acute Effects of Fruit Juices Consumption on Postprandial Glycemic Responses and Satiety

Start date: September 1, 2023
Phase: N/A
Study type: Interventional

This study investigated the acute effects of two fruit juices on postprandial glycemic responses and satiety in healthy individuals

NCT ID: NCT06146322 Completed - Diabetes Clinical Trials

Barley Beta-glucan, Glycemic Control, and Appetite

Start date: October 1, 2019
Phase: N/A
Study type: Interventional

Novel barley varieties high in the soluble fiber β-glucan have the capacity to improve population health through improving glycemic control. Sweetened and unsweetened wholegrain barley foods were tested in a randomized, controlled, crossover human clinical trial to assess impact on postprandial appetite and food intake.

NCT ID: NCT05957185 Completed - Appetitive Behavior Clinical Trials

Effects of Microbial Protease Supplementation on Postprandial Plasma Amino Acid Concentrations and Appetite

Start date: August 7, 2023
Phase: N/A
Study type: Interventional

The primary purpose of this study is to assess the effect of co-ingestion of microbial proteases and whey protein concentrate (WPC) on postprandial plasma amino acid concentrations in healthy adult participants compared to WPC with placebo. The secondary purpose is to assess the effect of co-ingestion of microbial proteases and WPC on postprandial glycemic response, subjective appetite sensations, gut-derived appetite regulating hormones, ad libitum meal intake, and gastrointestinal tolerability in healthy adult participants compared to WPC with placebo.

NCT ID: NCT05825963 Completed - Obesity Clinical Trials

Psyllium-enriched Hamburger Meatballs: Effects on Postprandial Lipidemia, Glycemia, Appetite, and Food Intake

Start date: April 12, 2022
Phase: N/A
Study type: Interventional

The goal of this clinical trial is to enrich the hamburger meatball with psyllium without impairing its sensory properties and to investigate the effects on acute postprandial lipemia and glycemia, prospective food intake, and some appetite indicators in healthy adults. The main hypotheses of the study are: 1. There is no difference in sensory analysis results between hamburger meatballs enriched with psyllium and those that are not enriched. 2. The rise in postprandial lipids after consuming psyllium-enriched hamburger meatballs is lower than that of classic hamburgers. 3. The rise in postprandial glycemia after consuming psyllium-enriched hamburger meatballs is lower than that of classic hamburgers. 4. The feeling of satiety after consuming psyllium-enriched hamburger meatballs lasts longer, and the feeling of hunger lasts for a shorter period compared to classic hamburgers. 5. Daily food intake after consuming psyllium-enriched hamburger meatballs is less than that of classic hamburgers. Participants will, - Eat hamburgers, after fasting for 12 hours, with psyllium-enriched and classic meatballs on intervention days. - Keep a record of their food intake for the previous and following 24 hours of each intervention. - Be given fasting and postprandial blood samples. - Evaluate their hunger and satiety levels on a 100 mm horizontal visual analog scale (VAS) at the beginning and every hour for the following 6 hours of the study.

NCT ID: NCT05815641 Completed - Obesity Clinical Trials

Pre- and Post-prandial Levels of Appetite Regulatory Hormones in Adults

Start date: September 1, 2021
Phase: N/A
Study type: Interventional

The present study aims to evaluate in adults with normal weight and with overweight or obesity who live in the city of La Plata the circulating levels of various hormones that regulate appetite and the gene expression of their receptors in peripheral blood mononuclear cells before and after food intake.

NCT ID: NCT05810337 Completed - Clinical trials for Glucose Metabolism Disorders

Splenda: Effects on Blood Glucose Concentration, Appetite Scores and Subsequent Energy Intake

Start date: January 18, 2023
Phase: N/A
Study type: Interventional

This study investigates the effects of Splenda, an artificial sweetener powder containing sucralose, on post-prandial blood glucose levels, appetite scores and subsequent energy intake.

NCT ID: NCT05702372 Completed - Appetitive Behavior Clinical Trials

Acute Glycemic Effects of Crackers Made by Different Flours

Start date: September 19, 2022
Phase: N/A
Study type: Interventional

This study investigated the acute effects of cracker consumption made by different flours on glycemic responses.

NCT ID: NCT05702307 Completed - Appetitive Behavior Clinical Trials

Determining the Glycemic Effects of Sunflower Pasta

Start date: October 15, 2022
Phase: N/A
Study type: Interventional

This study investigated the effects of five types of pasta on the glycemic responses

NCT ID: NCT05528874 Completed - Hyperglycemia Clinical Trials

NUTRACORE, Glycaemic Index and Appetite

NTRCR-vivo
Start date: April 22, 2022
Phase: N/A
Study type: Interventional

In recent decades, the world prevalence of obesity and type 2 diabetes (DMT2) has increased dramatically, resulting in a global epidemic. One of the aspects more connected to the etiology of these pathologies is undoubtedly the concept of the glycemic index (GI) and glycemic load (CG). It has been shown that, with the same CG, that is of carbohydrates contained in a food, a food with a higher GI tends to raise blood sugar more quickly (and consequently insulin), causing several negative effects on the body. We now have sufficient evidence to show that high GI diets are associated with increased incidence of DMT2, hyperlipoproteinemia, and cardiovascular disease. Although simple carbohydrates, namely sugars, have always been considered the major inducers of hyperglycemia and hyperinsulinemia, in reality also starches, or complex carbohydrates digestible by humans, may lead to an increase in blood sugar levels which is not as rapid but often equally harmful to health, since the GC is generally higher. The reason why a high GI diet is responsible for this increased risk of developing pathologies is not unambiguous. We can identify at least 4 probable mechanisms. 1. Sudden hyperglycemia tends to cause insulin to rise beyond what is necessary, leading subsequently to the risk of hypoglycemia and thus an excessive feeling of hunger. Increased energy intake and obesity. 2. Excess insulin secretion, aggravated by insulin resistance, represents an effort for the pancreas with the risk, over time, to arrive at a deficit of insulin-dependent diabetes type 2 insulin production 3. Hyperinsulinemia is also associated with reduced lipolysis and increased lipogenesis obesity and hyperlipoproteinemia 4. Fat accumulation, especially in the abdominal region, is associated with chronic inflammation and insulin resistance by type 2 diabetes tissues and metabolic syndrome In addition to these reasons, a high GI diet, typically called Western Diet, is also generally deficient in plant foods, rich in antioxidants and photo compounds with anti-inflammatory action, without which the process of chronic organic inflammation is accelerated, even in the absence of real obesity.

NCT ID: NCT05484362 Completed - Blood Pressure Clinical Trials

Acute Effect of Crocus Sativus on Postprandial Glycemia

Start date: June 6, 2022
Phase: N/A
Study type: Interventional

This study investigated the effects of two different doses of Crocus Sativus in glucose beverages on glycemic responses.